An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2014 |
| Author/s |
author: Ihor Vynnychenko Igor N. Bondarenko |
| Publication date | October 15, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |